Apple F S, Sharkey S W, Werdick M, Elsperger K J, Tilbury R T
Clin Chem. 1987 Apr;33(4):507-11.
Isoenzymes and isoforms of creatine kinase (CK, EC 2.7.3.2) were measured to assess reperfusion after acute myocardial infarction (AMI). In streptokinase-treated and in spontaneously reperfused AMI patients, total CK, CK-2 activity and concentration, and CK-3(3) isoform activity peaked significantly (p less than 0.05) earlier than conventionally treated, non-reperfused patients. The ratio for CK-3(3) to CK-3(1) activities peaked significantly (p less than 0.05) earlier in both the streptokinase-treated and spontaneously reperfused groups, and indicated a greater release of enzyme (higher ratio) than in the conventionally treated patients. The ratio of CK-3(3)/3(1) also peaked significantly (p less than 0.05) earlier in all three groups than did total CK, CK-2, and CK-3(3) activities or concentrations. The clearance rates of total CK, CK-2, and CK-3(3) were not significantly different in all three groups. Thus, the ratio CK-3(3)/3(1) was the earliest indicator of infarction in both reperfused and non-reperfused patients.
测定肌酸激酶(CK,EC 2.7.3.2)的同工酶和亚型,以评估急性心肌梗死(AMI)后的再灌注情况。在接受链激酶治疗和自发再灌注的AMI患者中,总CK、CK-2活性和浓度以及CK-3(3)亚型活性达到峰值的时间显著早于传统治疗的未再灌注患者(p<0.05)。在链激酶治疗组和自发再灌注组中,CK-3(3)与CK-3(1)活性的比值达到峰值的时间均显著早于传统治疗组(p<0.05),且表明酶的释放量更大(比值更高)。CK-3(3)/3(1)的比值在所有三组中达到峰值的时间也显著早于总CK、CK-2和CK-3(3)的活性或浓度(p<0.05)。三组中总CK、CK-2和CK-3(3)的清除率无显著差异。因此,CK-3(3)/3(1)的比值是再灌注和未再灌注患者梗死的最早指标。